Date published: 2026-5-4

1-800-457-3801

SCBT Portrait Logo
Seach Input

tamsulosin (CAS 106133-20-4)

0.0(0)
Write a reviewAsk a question

Alternate Names:
(R)-5-(2-((2-(2-Ethoxyphenoxy)ethyl)amino)-propyl)-2-methoxybenzenesulfonamide
CAS Number:
106133-20-4
Purity:
≥97%
Molecular Weight:
408.516
Molecular Formula:
C20H28N2O5S
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Tamsulosin is a compound known for its selectivity as an alpha-1 adrenergic receptor antagonist, primarily used in non-clinical studies to understand smooth muscle dynamics. In research focused on urological conditions, tamsulosin is utilized to study its effects on smooth muscle relaxation, which provides insights into urinary retention mechanisms and bladder contractility. The compound′s specificity towards the alpha-1a and alpha-1d adrenergic receptor subtypes found in the urinary tract makes it a useful tool for probing the sympathetic nervous system′s control over urinary function. Additionally, investigations into tamsulosin′s action can inform the design of experiments looking at neurotransmitter release and receptor interaction, furthering the understanding of molecular signaling pathways. Its role in fundamental research contributes to a broader comprehension of muscle tone regulation and has implications for the study of various smooth muscle-related disorders.


tamsulosin (CAS 106133-20-4) References

  1. Tamsulosin versus terazosin for benign prostatic hyperplasia: a systematic review.  |  Dong, Z., et al. 2009. Syst Biol Reprod Med. 55: 129-36. PMID: 19886768
  2. Tamsulosin for voiding dysfunction in women.  |  Meyer, LE. and Brown, JN. 2012. Int Urol Nephrol. 44: 1649-56. PMID: 22983886
  3. Can tamsulosin facilitate expulsion of ureteral stones? A meta-analysis of randomized controlled trials.  |  Fan, B., et al. 2013. Int J Urol. 20: 818-30. PMID: 23278872
  4. Tamsulosin for treatment of lower urinary tract symptoms in women: a systematic review and meta-analysis.  |  Zhang, HL., et al. 2017. Int J Impot Res. 29: 148-156. PMID: 28424499
  5. Tamsulosin and the risk of dementia in older men with benign prostatic hyperplasia.  |  Duan, Y., et al. 2018. Pharmacoepidemiol Drug Saf. 27: 340-348. PMID: 29316005
  6. Tamsulosin-Associated Erythema Multiforme-Like Eruption.  |  Hu, L., et al. 2020. Am J Ther. 27: e700-e701. PMID: 31513023
  7. Comparison of Serenoa repens With Tamsulosin in the Treatment of Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis.  |  Cai, T., et al. 2020. Am J Mens Health. 14: 1557988320905407. PMID: 32274957
  8. Comparative Effectiveness of Tadalafil versus Tamsulosin in Treating Lower Urinary Tract Symptoms Suggestive of Benign Prostate Hyperplasia: A Meta-Analysis of Randomized Controlled Trials.  |  Guo, B., et al. 2020. Med Sci Monit. 26: e923179. PMID: 32327621
  9. Tadalafil Alone or in Combination with Tamsulosin for the Management for LUTS/BPH and ED.  |  Sebastianelli, A., et al. 2020. Curr Urol Rep. 21: 56. PMID: 33108544
  10. [Intraoperative floppy iris syndrom (IFIS) associated with tamsulosin].  |  Bigdon, E., et al. 2022. Aktuelle Urol. 53: 246-253. PMID: 33694138
  11. Intraoperative Floppy Iris Syndrome Induced by Tamsulosin: The Risk and Preventive Strategies.  |  Tobaiqy, M., et al. 2021. Middle East Afr J Ophthalmol. 28: 51-56. PMID: 34321822
  12. Tamsulosin facilitates depressive-like behaviors in mice: Involvement of endogenous glucocorticoids.  |  Holanda, VAD., et al. 2022. Brain Res Bull. 178: 29-36. PMID: 34798218
  13. Medical Treatment of Benign Prostatic Hyperplasia.  |  Plochocki, A. and King, B. 2022. Urol Clin North Am. 49: 231-238. PMID: 35428429

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

tamsulosin, 100 mg

sc-280105
100 mg
$250.00